{"id":64670,"date":"2025-12-25T13:22:59","date_gmt":"2025-12-25T04:22:59","guid":{"rendered":"https:\/\/www.marketresearch.co.jp\/insights\/advance-therapy-medicinal-products-market-mordor\/"},"modified":"2026-10-02T17:51:07","modified_gmt":"2026-10-02T08:51:07","slug":"advance-therapy-medicinal-products-market-mordor","status":"publish","type":"post","link":"https:\/\/www.marketresearch.co.jp\/insights\/advance-therapy-medicinal-products-market-mordor\/","title":{"rendered":"\u518d\u751f\u533b\u7642\u7b49\u88fd\u54c1 (ATMPs) \u5e02\u5834\u898f\u6a21\u30fb\u30b7\u30a7\u30a2\u5206\u6790 &#8211; \u6210\u9577\u52d5\u5411\u3068\u4e88\u6e2c (2025-2030\u5e74)"},"content":{"rendered":"<p><img decoding=\"async\" src=\"https:\/\/www.marketresearch.co.jp\/insights\/wp-content\/uploads\/2025\/12\/advance-therapy-medicinal-products-market_1646748886317_MAJOR_PLAYERS-scaled.webp\" alt=\"Chart\" class=\"aligncenter size-full\" \/><\/p>\n<p><img decoding=\"async\" src=\"https:\/\/www.marketresearch.co.jp\/insights\/wp-content\/uploads\/2025\/12\/advance-therapy-medicinal-products-market-size-image-1765458311649.webp\" alt=\"Chart\" class=\"aligncenter size-full\" \/><\/p>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-0\">\n    1. \u306f\u3058\u3081\u306b<\/p>\n<ul>\n<li class=\"toc-level-2\">\n          1.1 \u8abf\u67fb\u306e\u524d\u63d0\u6761\u4ef6\u3068\u5e02\u5834\u306e\u5b9a\u7fa9<\/p>\n<\/li>\n<li class=\"toc-level-2\">\n          1.2 \u8abf\u67fb\u7bc4\u56f2<\/p>\n<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-1\">\n    2. \u8abf\u67fb\u65b9\u6cd5<\/p>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-2\">\n    3. \u30a8\u30b0\u30bc\u30af\u30c6\u30a3\u30d6\u30b5\u30de\u30ea\u30fc<\/p>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-3\">\n    4. \u5e02\u5834\u306e\u30c0\u30a4\u30ca\u30df\u30af\u30b9<\/p>\n<ul>\n<li class=\"toc-level-2\">\n          4.1 \u5e02\u5834\u6982\u8981<\/p>\n<\/li>\n<li class=\"toc-level-2\">\n          4.2 \u5e02\u5834\u306e\u63a8\u9032\u8981\u56e0<\/p>\n<ul>\n<li class=\"toc-level-3\">\n          4.2.1 ATMP\u306e\u81e8\u5e8a\u8a66\u9a13\u6570\u306e\u5897\u52a0<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          4.2.2 \u5e02\u5834\u53c2\u52a0\u8005\u9593\u306e\u7af6\u4e89\u306e\u6fc0\u5316<\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">\n          4.3 \u5e02\u5834\u306e\u963b\u5bb3\u8981\u56e0<\/p>\n<ul>\n<li class=\"toc-level-3\">\n          4.3.1 \u8cbb\u7528\u5bfe\u52b9\u679c\u3068\u8ca1\u52d9\u7684\u6301\u7d9a\u53ef\u80fd\u6027\u306b\u95a2\u3059\u308b\u8ab2\u984c<\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">\n          4.4 \u30dd\u30fc\u30bf\u30fc\u306e5\u3064\u306e\u529b\u5206\u6790<\/p>\n<ul>\n<li class=\"toc-level-3\">\n          4.4.1 \u65b0\u898f\u53c2\u5165\u8005\u306e\u8105\u5a01<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          4.4.2 \u8cb7\u3044\u624b\/\u6d88\u8cbb\u8005\u306e\u4ea4\u6e09\u529b<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          4.4.3 \u4f9b\u7d66\u8005\u306e\u4ea4\u6e09\u529b<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          4.4.4 \u4ee3\u66ff\u54c1\u306e\u8105\u5a01<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          4.4.5 \u7af6\u4e89\u306e\u6fc0\u3057\u3055<\/p>\n<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-4\">\n    5. \u5e02\u5834\u30bb\u30b0\u30e1\u30f3\u30c6\u30fc\u30b7\u30e7\u30f3<\/p>\n<ul>\n<li class=\"toc-level-2\">\n          5.1 \u6cbb\u7642\u30bf\u30a4\u30d7\u5225<\/p>\n<ul>\n<li class=\"toc-level-3\">\n          5.1.1 \u7d30\u80de\u7642\u6cd5<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          5.1.2 \u907a\u4f1d\u5b50\u6cbb\u7642<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          5.1.3 CAR-T\u7642\u6cd5<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          5.1.4 \u7d44\u7e54\u5de5\u5b66\u88fd\u54c1<\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">\n          5.2 \u5730\u57df<\/p>\n<ul>\n<li class=\"toc-level-3\">\n          5.2.1 \u5317\u7c73<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.2.1.1 \u7c73\u56fd<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.2.1.2 \u30ab\u30ca\u30c0<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          5.2.2 \u30e8\u30fc\u30ed\u30c3\u30d1<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.2.2.1 \u30c9\u30a4\u30c4<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.2.2.2 \u30a4\u30ae\u30ea\u30b9<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.2.2.3 \u30d5\u30e9\u30f3\u30b9<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.2.2.4 \u30a4\u30bf\u30ea\u30a2<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.2.2.5 \u30b9\u30da\u30a4\u30f3<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.2.2.6 \u305d\u306e\u4ed6\u306e\u30e8\u30fc\u30ed\u30c3\u30d1<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          5.2.3 \u30a2\u30b8\u30a2\u592a\u5e73\u6d0b<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.2.3.1 \u4e2d\u56fd<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.2.3.2 \u65e5\u672c<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.2.3.3 \u30a4\u30f3\u30c9<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.2.3.4 \u30aa\u30fc\u30b9\u30c8\u30e9\u30ea\u30a2<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.2.3.5 \u97d3\u56fd<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.2.3.6 \u305d\u306e\u4ed6\u306e\u30a2\u30b8\u30a2\u592a\u5e73\u6d0b<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          5.2.4 \u305d\u306e\u4ed6\u306e\u5730\u57df<\/p>\n<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-5\">\n    6. \u7af6\u4e89\u74b0\u5883<\/p>\n<ul>\n<li class=\"toc-level-2\">\n          6.1 \u4f01\u696d\u30d7\u30ed\u30d5\u30a1\u30a4\u30eb<\/p>\n<ul>\n<li class=\"toc-level-3\">\n          6.1.1 \u30ce\u30d0\u30eb\u30c6\u30a3\u30b9AG<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          6.1.2 \u30ae\u30ea\u30a2\u30c9\u30fb\u30b5\u30a4\u30a8\u30f3\u30b7\u30ba\u793e<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          6.1.3 JCR\u30d5\u30a1\u30fc\u30de\u682a\u5f0f\u4f1a\u793e<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          6.1.4 \u30d6\u30ea\u30b9\u30c8\u30eb\u30fb\u30de\u30a4\u30e4\u30fc\u30ba \u30b9\u30af\u30a4\u30d6\u793e<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          6.1.5 F. \u30db\u30d5\u30de\u30f3\u30fb\u30e9\u30fb\u30ed\u30b7\u30e5\u793e<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          6.1.6 \u30d6\u30eb\u30fc\u30d0\u30fc\u30c9\u30fb\u30d0\u30a4\u30aa\u793e<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          6.1.7 \u30e6\u30cb\u30ad\u30e5\u30a2NV<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          6.1.8 \u30b3\u30ed\u30f3\u30fb\u30c6\u30a3\u30c3\u30b7\u30e5\u30b8\u30fc\u30f3\u793e<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          6.1.9 \u30d9\u30ea\u30bb\u30eb\u30fb\u30b3\u30fc\u30dd\u30ec\u30fc\u30b7\u30e7\u30f3<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          6.1.10 \u30d5\u30a1\u30fc\u30df\u30bb\u30eb\u682a\u5f0f\u4f1a\u793e<\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li><strong>*\u30ea\u30b9\u30c8\u306f\u7db2\u7f85\u7684\u3067\u306f\u3042\u308a\u307e\u305b\u3093 <\/strong><\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-6\">\n    7. \u5e02\u5834\u6a5f\u4f1a\u3068\u5c06\u6765\u306e\u30c8\u30ec\u30f3\u30c9<\/p>\n<div style=\"font-family: regular_semibold;\">\u5229\u7528\u53ef\u80fd\u6027\u306b\u3088\u308b<\/div>\n<div style=\"font-family: regular_semibold;\">\n    \u7af6\u5408\u60c5\u52e2\u306b\u306f\u3001\u4e8b\u696d\u6982\u8981\u3001\u8ca1\u52d9\u3001\u88fd\u54c1\u3068\u6226\u7565\u3001\u304a\u3088\u3073\u6700\u8fd1\u306e\u52d5\u5411\u304c\u542b\u307e\u308c\u307e\u3059\n  <\/div><\/p>\n","protected":false},"excerpt":{"rendered":"<p>\u5148\u9032\u533b\u7642\u88fd\u54c1\uff08ATMPs\uff09\u5e02\u5834\u306f\u30012025\u5e74\u304b\u30892030\u5e74\u306e\u4e88\u6e2c\u671f\u9593\u306b\u304a\u3044\u3066\u3001\u5e74\u5e73\u5747\u6210\u9577\u7387\uff08CAGR\uff0913.00%\u3067\u6210\u9577\u3059\u308b\u3068\u4e88\u6e2c\u3055\u308c\u3066\u3044\u307e\u3059\u3002\u672c\u5e02\u5834\u306f\u3001\u6cbb\u7642\u30bf\u30a4\u30d7\uff08\u7d30\u80de\u7642\u6cd5\u3001\u907a\u4f1d\u5b50\u7642\u6cd5\u3001CAR-T\u7d30\u80de\u7642\u6cd5\u3001\u7d44\u7e54\u5de5\u5b66\u88fd\u54c1\uff09\u304a\u3088\u3073\u5730\u57df\uff08\u5317\u7c73\u3001\u6b27\u5dde\u3001\u30a2\u30b8\u30a2\u592a\u5e73\u6d0b\u3001\u4e16\u754c\u306e\u305d\u306e\u4ed6\u306e\u5730\u57df\uff09\u306b\u3088\u3063\u3066\u30bb\u30b0\u30e1\u30f3\u30c8\u5316\u3055\u308c\u3066\u304a\u308a\u3001\u5404\u30bb\u30b0\u30e1\u30f3\u30c8\u306e\u4fa1\u5024\u306f\u7c73\u30c9\u30eb\u3067\u63d0\u4f9b\u3055\u308c\u307e\u3059\u3002\u8abf\u67fb\u671f\u9593\u306f2019\u5e74\u304b\u30892030\u5e74\u3001\u63a8\u5b9a\u306e\u57fa\u6e96\u5e74\u306f2024\u5e74\u3067\u3059\u3002\u6700\u3082\u6025\u901f\u306b\u6210\u9577\u3059\u308b\u5e02\u5834\u306f\u30a2\u30b8\u30a2\u592a\u5e73\u6d0b\u5730\u57df\u3067\u3042\u308a\u3001\u6700\u5927\u306e\u5e02\u5834\u306f\u5317\u7c73\u3067\u3059\u3002\u5e02\u5834\u306e\u96c6\u4e2d\u5ea6\u306f\u4e2d\u7a0b\u5ea6\u3068\u3055\u308c\u3066\u3044\u307e\u3059\u3002<\/p>\n<p>\u5e02\u5834\u6982\u8981<\/p>\n<p>\u5148\u9032\u533b\u7642\u88fd\u54c1\uff08ATMPs\uff09\u5e02\u5834\u306f\u3001\u4e88\u6e2c\u671f\u9593\u4e2d\u306b13%\u306eCAGR\u3092\u8a18\u9332\u3059\u308b\u3068\u4e88\u60f3\u3055\u308c\u3066\u3044\u307e\u3059\u3002COVID-19\u30d1\u30f3\u30c7\u30df\u30c3\u30af\u306f\u3001\u5f53\u521d\u3001\u4e16\u754c\u306e\u533b\u7642\u30b7\u30b9\u30c6\u30e0\u304cSARS-CoV-2\u611f\u67d3\u60a3\u8005\u306e\u7ba1\u7406\u306b\u6025\u907d\u79fb\u884c\u3057\u305f\u305f\u3081\u3001\u975eCOVID\u7528\u9014\u306e\u627f\u8a8d\u6e08\u307f\u5148\u9032\u6cbb\u7642\u88fd\u54c1\u304b\u3089\u306e\u53ce\u76ca\u3092\u4e00\u6642\u7684\u306b\u6e1b\u5c11\u3055\u305b\u307e\u3057\u305f\u3002\u3057\u304b\u3057\u3001\u305d\u306e\u5f8c\u3001COVID-19\u95a2\u9023\u306eATMPs\u306b\u5bfe\u3059\u308b\u9700\u8981\u304c\u6025\u5897\u3057\u307e\u3057\u305f\u3002\u4f8b\u3048\u3070\u30012022\u5e749\u6708\u306bNCBI\u304c\u767a\u8868\u3057\u305f\u8a18\u4e8b\u306b\u3088\u308b\u3068\u3001SARS-CoV-2\u611f\u67d3\u60a3\u8005\u306e\u6cbb\u7642\u3092\u76ee\u7684\u3068\u3057\u305f\u540c\u7a2eT\u7d30\u80de\u7642\u6cd5IND\u7533\u8acb\u3067\u3042\u308bALVR109\u304c\u7c73\u56fdFDA\u306e\u627f\u8a8d\u3092\u53d7\u3051\u307e\u3057\u305f\u3002\u307e\u305f\u30012021\u5e741\u6708\u306b\u306f\u3001Sorrento Therapeutics Inc.\u304c\u3001COVID-19\u8a98\u767a\u6025\u6027\u547c\u5438\u7aae\u8feb\u75c7\u5019\u7fa4\uff08ARDS\uff09\u307e\u305f\u306f\u6025\u6027\u547c\u5438\u7aae\u8feb\uff08ARD\uff09\u60a3\u8005\u5411\u3051\u306e\u30d2\u30c8\u540c\u7a2e\u8102\u80aa\u7531\u6765\u9593\u8449\u7cfb\u5e79\u7d30\u80de\u30d9\u30fc\u30b9\u6cbb\u7642\u85acCOVI-MSC\u306e\u7b2c1b\u76f8\u8a66\u9a13\u3067\u826f\u597d\u306a\u7d50\u679c\u3092\u5831\u544a\u3057\u307e\u3057\u305f\u3002\u3053\u306e\u3088\u3046\u306b\u3001CAR-T\u7d30\u80de\u306e\u975e\u816b\u760d\u5b66\u5206\u91ce\u3078\u306e\u5fdc\u7528\u62e1\u5927\u306f\u3001\u4e88\u6e2c\u671f\u9593\u4e2d\u306e\u53ce\u76ca\u6210\u9577\u306b\u8ca2\u732e\u3059\u308b\u3068\u671f\u5f85\u3055\u308c\u3066\u3044\u307e\u3059\u3002<\/p>\n<p>\u3055\u3089\u306b\u3001\u4e16\u754c\u306e\u30d1\u30a4\u30d7\u30e9\u30a4\u30f3\u306b\u304a\u3051\u308b\u5148\u9032\u6cbb\u7642\u5019\u88dc\u306e\u7d99\u7d9a\u7684\u306a\u5897\u52a0\u3082\u3001\u5c06\u6765\u306e\u5e02\u5834\u53ce\u76ca\u3092\u62bc\u3057\u4e0a\u3052\u308b\u3068\u4e88\u60f3\u3055\u308c\u307e\u3059\u30022021\u5e746\u6708\u306bNature Reviews Drug Discovery\u306b\u63b2\u8f09\u3055\u308c\u305f\u5206\u6790\u8a18\u4e8b\u3067\u306f\u3001\u4e16\u754c\u306e\u30d1\u30a4\u30d7\u30e9\u30a4\u30f3\u306b\u3042\u308b2,073\u306e\u7d30\u80de\u7642\u6cd5\u304c\u6d3b\u52d5\u4e2d\u3068\u3055\u308c\u30012020\u5e74\u306e\u66f4\u65b0\u6642\uff082021\u5e744\u670816\u65e5\u6642\u70b9\uff09\u304b\u3089572\u4ef6\u5897\u52a0\u3057\u307e\u3057\u305f\u3002\u3053\u308c\u306f\u3001\u4eca\u5f8c\u6570\u5e74\u9593\u306e\u5e02\u5834\u53ce\u76ca\u306b\u826f\u3044\u5f71\u97ff\u3092\u4e0e\u3048\u308b\u3068\u898b\u3089\u308c\u3066\u3044\u307e\u3059\u3002<\/p>\n<p>\u52a0\u3048\u3066\u3001\u5e02\u5834\u30b7\u30a7\u30a2\u3092\u7372\u5f97\u3059\u308b\u305f\u3081\u306e\u5e02\u5834\u53c2\u52a0\u8005\u9593\u306e\u7af6\u4e89\u6fc0\u5316\u304c\u3001\u5e02\u5834\u306b\u304a\u3051\u308b\u7814\u7a76\u958b\u767a\u6295\u8cc7\u306e\u6d41\u308c\u3092\u4fc3\u9032\u3059\u308b\u3068\u4e88\u60f3\u3055\u308c\u307e\u3059\u3002\u4f8b\u3048\u3070\u30012021\u5e7410\u6708\u306b\u306f\u3001Leucid Bio\u304c\u6b21\u4e16\u4ee3\u306e\u9769\u65b0\u7684\u306aCAR-T\u7642\u6cd5\u306e\u958b\u767a\u306e\u305f\u3081\u306b1,526\u4e07\u7c73\u30c9\u30eb\uff081\u82f1\u30dd\u30f3\u30c9\uff1d1.33\u7c73\u30c9\u30eb\uff09\u306e\u6295\u8cc7\u3092\u767a\u8868\u3057\u307e\u3057\u305f\u3002\u540c\u69d8\u306b\u30012021\u5e746\u6708\u306b\u306f\u3001Blackstone Life Sciences\u304cCellex Cell Professionals\u304a\u3088\u3073Intellia Therapeutics\u3068\u5354\u529b\u3057\u3001\u65b0\u3057\u3044CAR-T\u7d30\u80de\u7642\u6cd5\u4f1a\u793e\u3092\u7acb\u3061\u4e0a\u3052\u307e\u3057\u305f\u3002\u3053\u308c\u3089\u306e\u52d5\u5411\u306f\u3001\u5e02\u5834\u6210\u9577\u3092\u6c7a\u5b9a\u3059\u308b\u4e0a\u3067\u91cd\u8981\u306a\u5f79\u5272\u3092\u679c\u305f\u3059\u3068\u671f\u5f85\u3055\u308c\u3066\u3044\u307e\u3059\u3002<\/p>\n<p>\u3053\u306e\u3088\u3046\u306b\u3001ATMPs\u306e\u81e8\u5e8a\u8a66\u9a13\u6570\u306e\u5897\u52a0\u3068\u5e02\u5834\u53c2\u52a0\u8005\u9593\u306e\u7af6\u4e89\u6fc0\u5316\u306b\u3088\u308a\u3001\u5e02\u5834\u306f\u4e88\u6e2c\u671f\u9593\u4e2d\u306b\u6210\u9577\u3059\u308b\u3068\u4e88\u60f3\u3055\u308c\u307e\u3059\u3002\u3057\u304b\u3057\u3001\u624b\u9803\u306a\u4fa1\u683c\u3068\u8ca1\u653f\u7684\u6301\u7d9a\u53ef\u80fd\u6027\u306b\u95a2\u9023\u3059\u308b\u8ab2\u984c\u304c\u3001\u4e88\u6e2c\u671f\u9593\u4e2d\u306e\u5e02\u5834\u6210\u9577\u3092\u920d\u5316\u3055\u305b\u308b\u53ef\u80fd\u6027\u304c\u3042\u308a\u307e\u3059\u3002<\/p>\n<p>\u4e3b\u8981\u306a\u5e02\u5834\u30c8\u30ec\u30f3\u30c9<\/p>\n<p>\u7d44\u7e54\u5de5\u5b66\u88fd\u54c1\u30bb\u30b0\u30e1\u30f3\u30c8\u304c\u4e3b\u8981\u306a\u5e02\u5834\u30b7\u30a7\u30a2\u3092\u5360\u3081\u308b\u898b\u8fbc\u307f<br \/>\n\u7d44\u7e54\u5de5\u5b66\u88fd\u54c1\u30bb\u30b0\u30e1\u30f3\u30c8\u306e\u5927\u304d\u306a\u30b7\u30a7\u30a2\u306f\u3001\u3053\u306e\u30bb\u30b0\u30e1\u30f3\u30c8\u306b\u6bd4\u8f03\u7684\u591a\u6570\u306e\u5546\u696d\u7684\u306b\u627f\u8a8d\u3055\u308c\u305f\u88fd\u54c1\u304c\u5b58\u5728\u3059\u308b\u3053\u3068\u306b\u8d77\u56e0\u3057\u3066\u3044\u307e\u3059\u3002\u3055\u3089\u306b\u3001\u75c5\u6c17\u3084\u640d\u50b7\u3057\u305f\u8eab\u4f53\u90e8\u4f4d\u306e\u6a5f\u80fd\u56de\u5fa9\u3092\u5fc5\u8981\u3068\u3059\u308b\u6cbb\u7642\u624b\u9806\u306b\u304a\u3051\u308b\u7d44\u7e54\u5de5\u5b66\u88fd\u54c1\u306e\u5fdc\u7528\u62e1\u5927\u304c\u3001\u30bb\u30b0\u30e1\u30f3\u30c8\u306e\u6210\u9577\u3092\u727d\u5f15\u3057\u3066\u3044\u307e\u3059\u3002\u5e02\u5834\u53c2\u52a0\u8005\u306f\u3001\u88fd\u54c1\u306e\u63a1\u7528\u3092\u4fc3\u9032\u3059\u308b\u305f\u3081\u306b\u69d8\u3005\u306a\u5e02\u5834\u6226\u7565\u3092\u7d99\u7d9a\u7684\u306b\u5b9f\u65bd\u3057\u3066\u3044\u307e\u3059\u3002\u4f8b\u3048\u3070\u30012021\u5e741\u6708\u306b\u306f\u3001Vericel Corporation\u304cUnited Healthcare\u306b\u3088\u308bMACI\u306e\u533b\u7642\u4fdd\u967a\u9069\u7528\u7bc4\u56f2\u306e\u62e1\u5927\u3092\u767a\u8868\u3057\u307e\u3057\u305f\u3002\u3053\u306e\u62e1\u5927\u306b\u306f\u3001\u819d\u306e\u8907\u6570\u306e\u8edf\u9aa8\u6b20\u640d\u304a\u3088\u3073\u819d\u84cb\u9aa8\u306e\u75c7\u5019\u6027\u5168\u5c64\u8edf\u9aa8\u6b20\u640d\u3092\u6301\u3064\u60a3\u8005\u3078\u306e\u9069\u7528\u304c\u542b\u307e\u308c\u307e\u3059\u3002\u3053\u306e\u3088\u3046\u306a\u4f01\u696d\u306e\u53d6\u308a\u7d44\u307f\u304c\u3001\u30bb\u30b0\u30e1\u30f3\u30c8\u306e\u6210\u9577\u3092\u5927\u304d\u304f\u63a8\u9032\u3057\u3066\u3044\u307e\u3059\u30022021\u5e742\u6708\u306bAdvanced Functional Materials\u8a8c\u306b\u767a\u8868\u3055\u308c\u305f\u7814\u7a76\u3067\u306f\u3001\u5fc3\u7406\u7684\u523a\u6fc0\u306b\u53cd\u5fdc\u3057\u3066\u5f62\u72b6\u3092\u5909\u5316\u3055\u305b\u308b\u3053\u3068\u304c\u3067\u304d\u308b\u30cf\u30a4\u30c9\u30ed\u30b2\u30eb\u30d9\u30fc\u30b9\u306e\u6750\u6599\u306e\u958b\u767a\u304c\u793a\u3055\u308c\u307e\u3057\u305f\u3002\u3053\u308c\u306f\u3001\u81d3\u5668\u3001\u7d44\u7e54\u3001\u8840\u7ba1\u3001\u305d\u306e\u4ed6\u306e\u7ba1\u72b6\u69cb\u9020\u306e\u30d0\u30a4\u30aa\u30a8\u30f3\u30b8\u30cb\u30a2\u30ea\u30f3\u30b0\u306e\u305f\u3081\u306e\u6b21\u4e16\u4ee3\u6750\u6599\u3068\u3057\u3066\u5927\u304d\u306a\u53ef\u80fd\u6027\u3092\u79d8\u3081\u3066\u3044\u307e\u3059\u3002\u9769\u65b0\u7684\u306a\u7d44\u7e54\u5de5\u5b66\u88fd\u54c1\u306e\u958b\u767a\u306b\u5411\u3051\u305f\u7814\u7a76\u30d7\u30ed\u30b0\u30e9\u30e0\u306e\u7d76\u3048\u9593\u306a\u3044\u5897\u52a0\u3082\u3001\u30bb\u30b0\u30e1\u30f3\u30c8\u306e\u6210\u9577\u3092\u652f\u3048\u3066\u3044\u307e\u3059\u3002<\/p>\n<p>\u5317\u7c73\u304c\u4e3b\u8981\u306a\u5e02\u5834\u30b7\u30a7\u30a2\u3092\u5360\u3081\u3001\u4e88\u6e2c\u671f\u9593\u4e2d\u3082\u305d\u306e\u512a\u4f4d\u6027\u3092\u7dad\u6301\u3059\u308b\u3068\u4e88\u60f3<br \/>\n\u7c73\u56fd\u3092\u7b46\u982d\u3068\u3059\u308b\u5317\u7c73\u5730\u57df\u306f\u3001\u5f37\u529b\u306a\u898f\u5236\u67a0\u7d44\u307f\u3068\u8cc7\u91d1\u63d0\u4f9b\u6a5f\u95a2\u306e\u5b58\u5728\u306b\u3088\u308a\u3001\u4e3b\u8981\u306a\u30b7\u30a7\u30a2\u3092\u5360\u3081\u308b\u3068\u4e88\u60f3\u3055\u308c\u3066\u3044\u307e\u3059\u3002\u4f8b\u3048\u3070\u30012021\u5e747\u6708\u306b\u306f\u3001Kriya Therapeutics\u304c\u6b21\u4e16\u4ee3\u907a\u4f1d\u5b50\u7642\u6cd5\u306e\u8a2d\u8a08\u3068\u958b\u767a\u306e\u305f\u3081\u306e\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u3092\u63a8\u9032\u3059\u308b\u76ee\u7684\u3067\u3001\u30b7\u30ea\u30fc\u30baB\u8cc7\u91d1\u8abf\u9054\u30e9\u30a6\u30f3\u30c9\u30671\u5104\u7c73\u30c9\u30eb\u306e\u6295\u8cc7\u3092\u767a\u8868\u3057\u307e\u3057\u305f\u3002\u3055\u3089\u306b\u3001\u8fd1\u3044\u5c06\u6765\u306b\u3053\u306e\u5206\u91ce\u304b\u3089\u306e\u53ce\u76ca\u5229\u76ca\u304c\u5b9f\u73fe\u3055\u308c\u308b\u3053\u3068\u3092\u8a8d\u8b58\u3057\u3001\u5e02\u5834\u53c2\u52a0\u8005\u306f\u5e02\u5834\u3067\u306e\u5b58\u5728\u611f\u3092\u9ad8\u3081\u308b\u305f\u3081\u306b\u3001\u88fd\u54c1\u304a\u3088\u3073\u30b5\u30fc\u30d3\u30b9\u30dd\u30fc\u30c8\u30d5\u30a9\u30ea\u30aa\u306e\u62e1\u5927\u3092\u542b\u3080\u96c6\u4e2d\u7684\u306a\u53d6\u308a\u7d44\u307f\u3092\u884c\u3063\u3066\u3044\u307e\u3059\u3002\u4f8b\u3048\u3070\u30012021\u5e7412\u6708\u306b\u306f\u3001Novartis\u304c\u6b21\u4e16\u4ee3CAR-T\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u3068\u3057\u3066T-Charge\u3092\u7acb\u3061\u4e0a\u3052\u307e\u3057\u305f\u3002\u3053\u306e\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u306f\u3001Novartis\u306e\u65b0\u3057\u3044\u6cbb\u9a13\u7528CAR-T\u7d30\u80de\u7642\u6cd5\u306e\u57fa\u76e4\u3068\u3057\u3066\u6a5f\u80fd\u3059\u308b\u3088\u3046\u306b\u8a2d\u8a08\u3055\u308c\u3066\u3044\u307e\u3059\u3002\u3053\u308c\u3089\u306e\u958b\u767a\u306f\u3001\u5c06\u6765\u306e\u7c73\u56fd\u5e02\u5834\u3092\u5927\u304d\u304f\u62bc\u3057\u4e0a\u3052\u308b\u3068\u4e88\u60f3\u3055\u308c\u307e\u3059\u3002\u3057\u305f\u304c\u3063\u3066\u3001\u4e0a\u8a18\u306e\u8981\u56e0\u304c\u4e88\u6e2c\u671f\u9593\u4e2d\u306e\u3053\u306e\u5730\u57df\u306e\u5e02\u5834\u6210\u9577\u3092\u727d\u5f15\u3059\u308b\u3068\u671f\u5f85\u3055\u308c\u3066\u3044\u307e\u3059\u3002<\/p>\n<p>\u7af6\u4e89\u74b0\u5883<\/p>\n<p>\u5148\u9032\u533b\u7642\u88fd\u54c1\uff08ATMPs\uff09\u5e02\u5834\u306f\u73fe\u5728\u3001\u591a\u6570\u306e\u5927\u898f\u6a21\u304b\u3089\u4e2d\u5c0f\u898f\u6a21\u306e\u4f01\u696d\u304c\u5b58\u5728\u3057\u3001\u65ad\u7247\u5316\u3055\u308c\u305f\u6027\u8cea\u3092\u6301\u3063\u3066\u3044\u307e\u3059\u3002\u611f\u67d3\u5236\u5fa1\u30b5\u30fc\u30d3\u30b9\u304a\u3088\u3073\u88fd\u54c1\u306b\u304a\u3051\u308b\u6280\u8853\u7684\u9032\u6b69\u306e\u5897\u52a0\u306b\u4f34\u3044\u3001\u3088\u308a\u591a\u304f\u306e\u4f01\u696d\u304c\u5e02\u5834\u306b\u53c2\u5165\u3059\u308b\u3068\u4e88\u60f3\u3055\u308c\u307e\u3059\u3002\u73fe\u5728\u5e02\u5834\u3092\u652f\u914d\u3057\u3066\u3044\u308b\u4e3b\u8981\u4f01\u696d\u306b\u306f\u3001Novartis AG\u3001Gilead Sciences, Inc.\u3001JCR Pharmaceuticals Co. Ltd\u3001Bristol-Myers Squibb Company\u3001F. Hoffmann-La Roche Ltd.\u3001Bluebird Bio Inc.\u3001UniQure NV\u3001Kolon TissueGene Inc.\u3001Vericel Corporation\u3001PHARMICELL Co. Ltd.\u306a\u3069\u304c\u6319\u3052\u3089\u308c\u307e\u3059\u3002<\/p>\n<p>\u6700\u8fd1\u306e\u696d\u754c\u52d5\u5411<\/p>\n<p>*   2021\u5e742\u6708\uff1aBristol Myers Squibb\u306eCAR-T\u7642\u6cd5\u3067\u3042\u308bBreyanzi\u304c\u3001\u518d\u767a\u307e\u305f\u306f\u96e3\u6cbb\u6027\u5927\u7d30\u80de\u578bB\u7d30\u80de\u30ea\u30f3\u30d1\u816b\u306e\u6210\u4eba\u6cbb\u7642\u85ac\u3068\u3057\u3066\u7c73\u56fdFDA\u306e\u627f\u8a8d\u3092\u53d7\u3051\u307e\u3057\u305f\u3002<br \/>\n*   2021\u5e741\u6708\uff1aOrganogenesis Holding Inc.\u306f\u3001\u819d\u5909\u5f62\u6027\u95a2\u7bc0\u75c7\u306b\u95a2\u9023\u3059\u308b\u75c7\u72b6\u306e\u6cbb\u7642\u3092\u76ee\u7684\u3068\u3057\u305f\u51cd\u7d50\u4fdd\u5b58\u7f8a\u819c\u61f8\u6fc1\u6db2\u30a2\u30ed\u30b0\u30e9\u30d5\u30c8\u3067\u3042\u308bReNu\u306b\u5bfe\u3057\u3001FDA\u518d\u751f\u533b\u7642\u5148\u9032\u6cbb\u7642\uff08RMAT\uff09\u6307\u5b9a\u3092\u53d7\u3051\u307e\u3057\u305f\u3002<\/p>\n<p>\u3053\u306e\u30ec\u30dd\u30fc\u30c8\u306f\u3001\u300c\u4e16\u754c\u306e\u5148\u9032\u6cbb\u7642\u85ac\uff08ATMPs\uff09\u5e02\u5834\u300d\u306b\u95a2\u3059\u308b\u5305\u62ec\u7684\u306a\u5206\u6790\u3092\u63d0\u4f9b\u3057\u3066\u3044\u307e\u3059\u3002\u5148\u9032\u6cbb\u7642\u85ac\uff08ATMPs\uff09\u306f\u3001\u907a\u4f1d\u5b50\u3001\u7d44\u7e54\u3001\u307e\u305f\u306f\u7d30\u80de\u306b\u57fa\u3065\u3044\u305f\u75be\u60a3\u6cbb\u7642\u306e\u65b0\u3057\u3044\u65b9\u6cd5\u3067\u3042\u308a\u3001\u533b\u85ac\u54c1\u696d\u754c\u306b\u9769\u547d\u3092\u3082\u305f\u3089\u3059\u53ef\u80fd\u6027\u3092\u79d8\u3081\u3066\u3044\u307e\u3059\u3002\u672c\u30ec\u30dd\u30fc\u30c8\u306f\u3001\u5e02\u5834\u306e\u7bc4\u56f2\u3001\u52d5\u5411\u3001\u30bb\u30b0\u30e1\u30f3\u30c6\u30fc\u30b7\u30e7\u30f3\u3001\u7af6\u4e89\u74b0\u5883\u3001\u6a5f\u4f1a\u3001\u304a\u3088\u3073\u5c06\u6765\u306e\u30c8\u30ec\u30f3\u30c9\u3092\u8a73\u7d30\u306b\u8abf\u67fb\u3057\u3066\u3044\u307e\u3059\u3002<\/p>\n<p>1. \u8abf\u67fb\u306e\u7bc4\u56f2\u3068\u5b9a\u7fa9<br \/>\n\u30ec\u30dd\u30fc\u30c8\u306e\u7bc4\u56f2\u306b\u304a\u3044\u3066\u3001\u5148\u9032\u6cbb\u7642\u85ac\u306f\u3001\u907a\u4f1d\u5b50\u3001\u7d44\u7e54\u3001\u307e\u305f\u306f\u7d30\u80de\u3092\u57fa\u76e4\u3068\u3057\u305f\u75be\u60a3\u6cbb\u7642\u306e\u9769\u65b0\u7684\u306a\u30a2\u30d7\u30ed\u30fc\u30c1\u3068\u5b9a\u7fa9\u3055\u308c\u3066\u3044\u307e\u3059\u3002\u5e02\u5834\u306f\u3001\u6cbb\u7642\u30bf\u30a4\u30d7\u5225\uff08\u7d30\u80de\u7642\u6cd5\u3001\u907a\u4f1d\u5b50\u7642\u6cd5\u3001CAR-T\u7642\u6cd5\u3001\u7d44\u7e54\u5de5\u5b66\u88fd\u54c1\uff09\u3068\u5730\u57df\u5225\uff08\u5317\u7c73\u3001\u30e8\u30fc\u30ed\u30c3\u30d1\u3001\u30a2\u30b8\u30a2\u592a\u5e73\u6d0b\u3001\u305d\u306e\u4ed6\u306e\u5730\u57df\uff09\u306b\u30bb\u30b0\u30e1\u30f3\u30c8\u5316\u3055\u308c\u3066\u3044\u307e\u3059\u3002\u307e\u305f\u3001\u4e16\u754c\u306e\u4e3b\u8981\u5730\u57df\u306b\u308f\u305f\u308b14\u30ab\u56fd\u306e\u5e02\u5834\u898f\u6a21\u3068\u30c8\u30ec\u30f3\u30c9\u304cUSD\u767e\u4e07\u5358\u4f4d\u3067\u63d0\u4f9b\u3055\u308c\u3066\u3044\u307e\u3059\u3002<\/p>\n<p>2. \u5e02\u5834\u306e\u52d5\u5411<br \/>\n*   \u5e02\u5834\u306e\u63a8\u9032\u8981\u56e0: ATMPs\u306e\u81e8\u5e8a\u8a66\u9a13\u6570\u306e\u5897\u52a0\u3068\u3001\u5e02\u5834\u53c2\u5165\u4f01\u696d\u9593\u306e\u7af6\u4e89\u6fc0\u5316\u304c\u4e3b\u306a\u63a8\u9032\u8981\u56e0\u3068\u3057\u3066\u6319\u3052\u3089\u308c\u307e\u3059\u3002\u3053\u308c\u3089\u306e\u8981\u56e0\u304c\u5e02\u5834\u306e\u6210\u9577\u3092\u52a0\u901f\u3055\u305b\u3066\u3044\u307e\u3059\u3002<br \/>\n*   \u5e02\u5834\u306e\u6291\u5236\u8981\u56e0: \u6cbb\u7642\u306e\u8cbb\u7528\u5bfe\u52b9\u679c\u3068\u8ca1\u653f\u7684\u6301\u7d9a\u53ef\u80fd\u6027\u306b\u95a2\u9023\u3059\u308b\u8ab2\u984c\u304c\u3001\u5e02\u5834\u306e\u6210\u9577\u3092\u6291\u5236\u3059\u308b\u8981\u56e0\u3068\u306a\u3063\u3066\u3044\u307e\u3059\u3002<br \/>\n*   \u30dd\u30fc\u30bf\u30fc\u306e\u30d5\u30a1\u30a4\u30d6\u30d5\u30a9\u30fc\u30b9\u5206\u6790: \u65b0\u898f\u53c2\u5165\u306e\u8105\u5a01\u3001\u8cb7\u3044\u624b\/\u6d88\u8cbb\u8005\u306e\u4ea4\u6e09\u529b\u3001\u4f9b\u7d66\u8005\u306e\u4ea4\u6e09\u529b\u3001\u4ee3\u66ff\u88fd\u54c1\u306e\u8105\u5a01\u3001\u7af6\u4e89\u306e\u6fc0\u3057\u3055\u3068\u3044\u3063\u305f\u89b3\u70b9\u304b\u3089\u3001\u5e02\u5834\u306e\u7af6\u4e89\u74b0\u5883\u304c\u8a73\u7d30\u306b\u5206\u6790\u3055\u308c\u3066\u3044\u307e\u3059\u3002<\/p>\n<p>3. \u5e02\u5834\u306e\u30bb\u30b0\u30e1\u30f3\u30c6\u30fc\u30b7\u30e7\u30f3<br \/>\n*   \u6cbb\u7642\u30bf\u30a4\u30d7\u5225:<br \/>\n    *   \u7d30\u80de\u7642\u6cd5<br \/>\n    *   \u907a\u4f1d\u5b50\u7642\u6cd5<br \/>\n    *   CAR-T\u7642\u6cd5<br \/>\n    *   \u7d44\u7e54\u5de5\u5b66\u88fd\u54c1<br \/>\n*   \u5730\u57df\u5225:<br \/>\n    *   \u5317\u7c73: \u7c73\u56fd\u3001\u30ab\u30ca\u30c0<br \/>\n    *   \u30e8\u30fc\u30ed\u30c3\u30d1: \u30c9\u30a4\u30c4\u3001\u82f1\u56fd\u3001\u30d5\u30e9\u30f3\u30b9\u3001\u30a4\u30bf\u30ea\u30a2\u3001\u30b9\u30da\u30a4\u30f3\u3001\u305d\u306e\u4ed6\u306e\u30e8\u30fc\u30ed\u30c3\u30d1<br \/>\n    *   \u30a2\u30b8\u30a2\u592a\u5e73\u6d0b: \u4e2d\u56fd\u3001\u65e5\u672c\u3001\u30a4\u30f3\u30c9\u3001\u30aa\u30fc\u30b9\u30c8\u30e9\u30ea\u30a2\u3001\u97d3\u56fd\u3001\u305d\u306e\u4ed6\u306e\u30a2\u30b8\u30a2\u592a\u5e73\u6d0b<br \/>\n    *   \u305d\u306e\u4ed6\u306e\u5730\u57df<\/p>\n<p>4. \u4e3b\u8981\u306a\u8abf\u67fb\u7d50\u679c\u3068\u4e88\u6e2c<br \/>\n*   \u5e02\u5834\u898f\u6a21\u3068\u6210\u9577\u7387: \u5148\u9032\u6cbb\u7642\u85ac\u5e02\u5834\u306f\u3001\u4e88\u6e2c\u671f\u9593\uff082025\u5e74\u304b\u30892030\u5e74\uff09\u306b\u304a\u3044\u3066\u5e74\u5e73\u5747\u6210\u9577\u7387\uff08CAGR\uff0913%\u3092\u8a18\u9332\u3059\u308b\u3068\u4e88\u6e2c\u3055\u308c\u3066\u3044\u307e\u3059\u3002<br \/>\n*   \u4e3b\u8981\u306a\u5e02\u5834\u30b7\u30a7\u30a2: 2025\u5e74\u306b\u306f\u3001\u5317\u7c73\u304c\u5148\u9032\u6cbb\u7642\u85ac\u5e02\u5834\u306b\u304a\u3044\u3066\u6700\u5927\u306e\u5e02\u5834\u30b7\u30a7\u30a2\u3092\u5360\u3081\u308b\u3068\u898b\u8fbc\u307e\u308c\u3066\u3044\u307e\u3059\u3002<br \/>\n*   \u6700\u3082\u6025\u901f\u306b\u6210\u9577\u3059\u308b\u5730\u57df: \u30a2\u30b8\u30a2\u592a\u5e73\u6d0b\u5730\u57df\u306f\u3001\u4e88\u6e2c\u671f\u9593\uff082025\u5e74\u304b\u30892030\u5e74\uff09\u306b\u304a\u3044\u3066\u6700\u3082\u9ad8\u3044CAGR\u3067\u6210\u9577\u3059\u308b\u3068\u63a8\u5b9a\u3055\u308c\u3066\u3044\u307e\u3059\u3002<br \/>\n*   \u8abf\u67fb\u5bfe\u8c61\u671f\u9593: \u30ec\u30dd\u30fc\u30c8\u306f\u30012019\u5e74\u304b\u30892024\u5e74\u307e\u3067\u306e\u904e\u53bb\u306e\u5e02\u5834\u898f\u6a21\u30c7\u30fc\u30bf\u3068\u30012025\u5e74\u304b\u30892030\u5e74\u307e\u3067\u306e\u5e02\u5834\u898f\u6a21\u4e88\u6e2c\u3092\u30ab\u30d0\u30fc\u3057\u3066\u3044\u307e\u3059\u3002<\/p>\n<p>5. \u7af6\u4e89\u74b0\u5883<br \/>\n\u672c\u30ec\u30dd\u30fc\u30c8\u3067\u306f\u3001Novartis AG\u3001Gilead Sciences, Inc.\u3001JCR Pharmaceuticals Co. Ltd\u3001Bristol-Myers Squibb Company\u3001F. Hoffmann-La Roche Ltd\u3001Bluebird Bio Inc.\u3001UniQure NV\u3001Kolon TissueGene Inc.\u3001Vericel Corporation\u3001PHARMICELL Co. Ltd\u306a\u3069\u306e\u4e3b\u8981\u4f01\u696d\u306e\u30d7\u30ed\u30d5\u30a1\u30a4\u30eb\u304c\u8a73\u7d30\u306b\u5206\u6790\u3055\u308c\u3066\u3044\u307e\u3059\u3002\u3053\u308c\u3089\u306e\u4f01\u696d\u30d7\u30ed\u30d5\u30a1\u30a4\u30eb\u306b\u306f\u3001\u4e8b\u696d\u6982\u8981\u3001\u8ca1\u52d9\u72b6\u6cc1\u3001\u88fd\u54c1\u3068\u6226\u7565\u3001\u6700\u8fd1\u306e\u52d5\u5411\u304c\u542b\u307e\u308c\u3066\u3044\u307e\u3059\u3002<\/p>\n<p>6. \u5e02\u5834\u306e\u6a5f\u4f1a\u3068\u5c06\u6765\u306e\u30c8\u30ec\u30f3\u30c9<br \/>\n\u30ec\u30dd\u30fc\u30c8\u306f\u3001\u5e02\u5834\u306b\u304a\u3051\u308b\u65b0\u305f\u306a\u6a5f\u4f1a\u3068\u5c06\u6765\u306e\u30c8\u30ec\u30f3\u30c9\u306b\u3064\u3044\u3066\u3082\u8a00\u53ca\u3057\u3066\u304a\u308a\u3001\u95a2\u4fc2\u8005\u304c\u6226\u7565\u7684\u306a\u610f\u601d\u6c7a\u5b9a\u3092\u884c\u3046\u4e0a\u3067\u8cb4\u91cd\u306a\u6d1e\u5bdf\u3092\u63d0\u4f9b\u3057\u307e\u3059\u3002<\/p>\n<p>\u3053\u306e\u30ec\u30dd\u30fc\u30c8\u306f\u3001\u5148\u9032\u6cbb\u7642\u85ac\u5e02\u5834\u306e\u5168\u4f53\u50cf\u3092\u628a\u63e1\u3057\u3001\u5c06\u6765\u306e\u6210\u9577\u6226\u7565\u3092\u7b56\u5b9a\u3059\u308b\u305f\u3081\u306e\u91cd\u8981\u306a\u60c5\u5831\u6e90\u3068\u306a\u308b\u3067\u3057\u3087\u3046\u3002<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/www.marketresearch.co.jp\/insights\/wp-json\/wp\/v2\/posts\/64670"}],"collection":[{"href":"https:\/\/www.marketresearch.co.jp\/insights\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketresearch.co.jp\/insights\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketresearch.co.jp\/insights\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketresearch.co.jp\/insights\/wp-json\/wp\/v2\/comments?post=64670"}],"version-history":[{"count":1,"href":"https:\/\/www.marketresearch.co.jp\/insights\/wp-json\/wp\/v2\/posts\/64670\/revisions"}],"predecessor-version":[{"id":64673,"href":"https:\/\/www.marketresearch.co.jp\/insights\/wp-json\/wp\/v2\/posts\/64670\/revisions\/64673"}],"wp:attachment":[{"href":"https:\/\/www.marketresearch.co.jp\/insights\/wp-json\/wp\/v2\/media?parent=64670"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketresearch.co.jp\/insights\/wp-json\/wp\/v2\/categories?post=64670"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketresearch.co.jp\/insights\/wp-json\/wp\/v2\/tags?post=64670"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}